Sine Health Receives FDA 510(k) Clearance for the First Smartphone Essential Tremor Monitoring Device

Sine Health Receives FDA 510(k) Clearance for the First Smartphone Essential Tremor Monitoring Device

PR Newswire

Sine measures tremor passively through a patient’s own smartphone. It is the company’s second FDA clearance since founding last year

STOCKHOLM, Nov. 17, 2026 /PRNewswire/ — Sine Health today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K261026) for Sine, its smartphone-based essential tremor monitoring system.

Sine Health Logo

Sine measures tremor passively as patients go about their day, using the sensors already in their smartphone. Like a step counter, the app works in the background, giving clinicians an objective view of how a patient’s tremor changes between visits. Sine is the first FDA-cleared way to monitor essential tremor using only a smartphone.

Essential tremor affects about 7 million Americans. Despite its prevalence, patients are often not optimized on medication and/or surgery as clinicians largely judge tremor from brief observations intermittently in the clinic. “With several new therapies for essential tremor arriving the need to measure how patients actually do at home is growing,” said Jakob Gerstl, MBBS, MPH, founder and CEO of Sine Health.”

The clearance follows FDA clearance in June 2026 of Sine Health’s Parkinson’s disease monitoring system using Apple Watches.

About Sine Health
Sine Health (formerly Nordic Kinetics) builds a new form of neurologic assessment, turning smartphone/wearable sensor streams into a continuous, objective, AI-based neurological examination.

sinehealth.com

Contact: Jakob Gerstl, info@sinehealth.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sine-health-receives-fda-510k-clearance-for-the-first-smartphone-essential-tremor-monitoring-device-302942052.html

SOURCE Sine Health